Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 4

Managing Skin Manifestations and Organ Involvement in GVHD

Panelists discuss how to monitor patients with chronic GvHDGVHD on steroids as first-line treatment, emphasizing the importance of early recognition and management of skin rash in patients with GvHDGVHD patients, and highlighting the critical role of prompt intervention in preventing complications.

EP. 1: Understanding Graft-VS-Host Disease (GVHD) Basics
EP. 2: Early Diagnosis and Intervention in GVHD Part 1
EP. 3: Early Diagnosis and Intervention in GVHD Part 2
Now Viewing
EP. 4: Managing Skin Manifestations and Organ Involvement in GVHD
EP. 5: Treatment Decision-Making in Chronic GVHD
EP. 6: NCCN Guidelines and Clinical Updates in Chronic GVHD
EP. 7: FDA-Approved Therapies for Chronic GVHD
EP. 8: Challenges, Limitations, and Treatment Sequencing in Chronic GVHD
EP. 9: Future Perspectives and Key Takeaways

Video content above is prompted by the following:

  • How do you monitor patients with chronic GvHDGVHD who are on steroids as first-line treatment?
  • How do you approach the early recognition and management of skin rash in patients with GvHDGVHD patients?
  • What is the importance of prompt intervention in this setting?